Business
Is the CSL (ASX:CSL) vaccine business under threat?
Image source: Getty Images
The CSL Limited (ASX: CSL) share price has been underperforming the ASX 200 in 2021.
Since the start of the year, the biotherapeutics company’s shares are down 2%. This compares to a 10% gain by the benchmark index.
Why is the CSL share price…
Continue Reading
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Business23 hours agoASX ETFs to target amidst an ageing population
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News23 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’